XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (17,527,000) $ (3,526,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 495,000 250,000
Depreciation 178,000 1,000
Amortization of intangible assets 135,000  
Changes in operating assets and liabilities:    
Prepaid and other assets (1,063,000) 185,000
Operating lease right-of-use assets and liabilities (1,000) 25,000
Accounts payable (3,794,000) (47,000)
Accrued development expense 122,000 834,000
Accrued compensation and benefits (1,705,000) 16,000
Other liabilities (370,000) (44,000)
Net cash used in operating activities (23,530,000) (2,306,000)
Cash flows from investing activities:    
Purchases of property and equipment (425,000)  
Net cash used in investing activities (425,000)  
Cash flows from financing activities:    
Proceeds from issuance of common stock upon exercise of stock options 211,000 475,000
Proceeds from issuance of common stock upon exercise of common stock warrants 0 692,000
Proceeds from common stock offering, net of issuance costs   189,825,000
Net cash provided by financing activities 211,000 190,992,000
Net (decrease) increase in cash and cash equivalents (23,744,000) 188,686,000
Cash and cash equivalents at beginning of period 233,437,000 93,506,000
Cash and cash equivalents at end of period $ 209,693,000 $ 282,192,000